echemi logo
web-logo
slogan
homepage
Product
  • Product
  • Supplier
  • Inquiry

    My ECHEMI

    EN

    Home > Medical News > Medical Research Articles > Data from the world's first phase III study of oral TYK2 allosteric inhibitor deuscravacitinib in Asian populations were released

    Data from the world's first phase III study of oral TYK2 allosteric inhibitor deuscravacitinib in Asian populations were released

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Tags

    steroids arthritis

    material pa6 6
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com